Literature DB >> 21597023

Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.

Sabine Tejpar, Zacharenia Saridaki, Mauro Delorenzi, Fred Bosman, Arnaud D Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21597023     DOI： 10.1093/jnci/djr170

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  23 in total

1.  Turning up the heat on colorectal cancer.

Authors:  Andrew T Chan
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

2.  Molecular classification of colorectal cancer using the gene expression profile of tumor samples.

Authors:  Mamoon Rashid; Ramesh K Vishwakarma; Ahmad M Deeb; Mohamed A Hussein; Mohammad A Aziz
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-15

3.  Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).

Authors:  Pilar García-Alfonso; Ramón Salazar; Jesús García-Foncillas; Eva Musulén; Rocío García-Carbonero; Artemio Payá; Pedro Pérez-Segura; Santiago Ramón y Cajal; Samuel Navarro
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

Review 4.  The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.

Authors:  Ha Thi Nguyen; Hong-Quan Duong
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

5.  Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.

Authors:  Zhaohui Jin; Cristobal T Sanhueza; Benny Johnson; David M Nagorney; David W Larson; Kristin C Mara; William C Harmsen; Thomas C Smyrk; Axel Grothey; Joleen M Hubbard
Journal:  Oncologist       Date:  2018-04-19

Review 6.  Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.

Authors:  Larissa V Furtado; Wade S Samowitz
Journal:  Virchows Arch       Date:  2017-05-27       Impact factor: 4.064

7.  Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?

Authors:  Deborah Cragun; Rita D DeBate; Tuya Pal
Journal:  J Genet Couns       Date:  2014-10-18       Impact factor: 2.537

8.  Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Authors:  J Goldstein; B Tran; J Ensor; P Gibbs; H L Wong; S F Wong; E Vilar; J Tie; R Broaddus; S Kopetz; J Desai; M J Overman
Journal:  Ann Oncol       Date:  2014-02-27       Impact factor: 32.976

9.  CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.

Authors:  Lorraine Pelosof; Sashidhar R Yerram; Nita Ahuja; Andrew Delmas; Ludmila Danilova; James G Herman; Nilofer S Azad
Journal:  Int J Cancer       Date:  2013-08-24       Impact factor: 7.396

Review 10.  Prognostic and predictive significance of MSI in stages II/III colon cancer.

Authors:  Zacharenia Saridaki; John Souglakos; Vassilis Georgoulias
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.